Raptor Pharma (RPTP) Reports In-Line Q1 EPS

Raptor Pharma (NASDAQ: RPTP) reported Q1 EPS of ($0.17), in-line with the analyst estimate of ($0.17). Revenue for the quarter came in at $27.5 million versus the consensus estimate of $27.17 million.

For earnings history and earnings-related data on Raptor Pharma (RPTP) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Is Treasury selloff a major issue for stock market bulls?
• InspireMD (NSPR) Tops Q2 EPS by 1c